-
41
Effects of Alzheimer’s disease plasma marker levels on multilayer centrality in healthy individuals
Published 2025-01-01Subjects: Get full text
Article -
42
The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment
Published 2023-05-01Subjects: Get full text
Article -
43
-
44
Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer’s disease: a systematic review and network meta-analysis of...
Published 2025-01-01Subjects: “…anti-tau protein monoclonal antibodies…”
Get full text
Article -
45
Rheological monitoring of tau protein polymerisation with acoustic waves sensor
Published 2017-03-01Subjects: Get full text
Article -
46
-
47
A comparison of computational efficiencies of stochastic algorithms in terms of two infection models
Published 2012-06-01Subjects: Get full text
Article -
48
-
49
Short-term variability of Alzheimer’s disease plasma biomarkers in a mixed memory clinic cohort
Published 2025-01-01Subjects: “…Intra- and Inter-individual variability, Reference change value (RCV), Plasma Aβ42/Aβ40 ratio, Phosphorylated tau (p-tau), Neurofilament light (NfL), Glial fibrillary acidic protein (GFAP)…”
Get full text
Article -
50
The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer’s disease and primary tauopathies
Published 2025-01-01Subjects: Get full text
Article -
51
T-006改善<italic>APP/PS1/Tau</italic>转基因小鼠学习记忆功能及调控突触相关蛋白表达
Published 2021-09-01Subjects: Get full text
Article -
52
Análisis de frecuencias de crecientes trivariados con dependencia regional y funciones Cópula
Published 2025-01-01Subjects: Get full text
Article